Knoll Capital Management, LLC
MIAMI, FL · CIK 1325083 · 13F filing filed 2025-11-14
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Others nearbyMiami, FL
$186.6m
reported value
+32.7% vs Q2 2025
38positions
64.1%in top 10
3 new
0 added
3 reduced
3 sold out
vs Q2 2025
Holdings, Q3 2025
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ALDEYRA THERAPEUTICS INC ALDX | $28.6m15.32% | Unchanged |
| BIOHAVEN PHARMACTL HLDG CO L BHVN | $13.4m7.20% | Unchanged |
| SPDR GOLD TR GLD | $11.4m6.10% | Unchanged |
| ENTERA BIO LTD ENTX | $11.3m6.05% | Unchanged |
| MEIRAGTX HLDGS PLC MGTX | $10.3m5.51% | Unchanged |
| KINROSS GOLD CORP KGC | $10.2m5.46% | Reduced -30.0k |
| AVADEL PHARMACEUTICALS PLC SPONSORED ADR | $9.2m4.91% | Unchanged |
| AGNICO EAGLE MINES LTD AEM | $8.9m4.76% | Reduced -2.8k |
| SANDSTORM GOLD LTD SSL | $8.8m4.70% | Unchanged |
| SEABRIDGE GOLD INC COM | $7.7m4.10% | Unchanged |
| OCULAR THERAPEUTIX INC OCUL | $7.0m3.76% | Unchanged |
| ELICIO THERAPEUTICS INC ELTX | $6.9m3.70% | Unchanged |
| FRANCO NEV CORP FNV | $5.6m2.99% | Unchanged |
| NUVATION BIO INC NUVB | $5.5m2.97% | Unchanged |
| CENTERRA GOLD INC CGAU | $5.3m2.86% | Reduced -730.5k |
| APPLIED THERAPEUTICS INC APLT | $4.7m2.52% | Unchanged |
| ALTIMMUNE INC ALT | $4.2m2.27% | Unchanged |
| PAN AMERN SILVER CORP PAAS | $3.9m2.08% | New |
| ISHARES SILVER TR SLV | $3.4m1.82% | Unchanged |
| ROYAL GOLD INC RGLD | $1.8m0.97% | Unchanged |
| COEUR MNG INC CDE | $1.8m0.97% | Unchanged |
| ALAMOS GOLD INC NEW AGI | $1.7m0.93% | Unchanged |
| TRIPLE FLAG PRECIOUS METAL TFPM | $1.7m0.92% | New |
| VISA INC V | $1.7m0.89% | Unchanged |
| PHILIP MORRIS INTL INC PM | $1.6m0.87% | Unchanged |
| ISHARES TR ITA | $1.6m0.86% | Unchanged |
| WHEATON PRECIOUS METALS CORP WPM | $1.4m0.75% | Unchanged |
| NORTHROP GRUMMAN CORP NOC | $1.3m0.71% | Unchanged |
| NEW PAC METALS CORP NEWP | $1.3m0.70% | Unchanged |
| BOOZ ALLEN HAMILTON HLDG COR BAH | $1.3m0.70% | Unchanged |
| DIAGEO PLC DEO | $644.2k0.35% | Unchanged |
| DAKOTA GOLD CORP DC | $559.3k0.30% | New |
| MEREO BIOPHARMA GROUP PLC MREO | $536.6k0.29% | Unchanged |
| HOOKIPA PHARMA INC COM | $461.2k0.25% | Unchanged |
| ORCHESTRA BIOMED HLDGS INC OBIO | $421.2k0.23% | Unchanged |
| ABEONA THERAPEUTICS INC ABEO | $331.0k0.18% | Unchanged |
| CARDIOL THERAPEUTICS INC CRDL | $107.0k0.06% | Unchanged |
| Orgenesis, Inc. COM | $50.6k0.03% | Unchanged |
Sold out since Q2 2025
| Security | Value then |
|---|---|
| SKEENA RES LTD NEW SKE | $4.7m295.4k shares |
| MAG SILVER CORP MAG | $3.6m170.0k shares |
| VERONA PHARMA PLC VRNA | $666.7k7.0k shares |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| ELICIO THERAPEUTICS INC ELTX · 13G · filed 2026-07-08 | 5.3%≈ $4.7m |